Showing 1 - 20 results of 53 for search 'Filip K Knop', 查询时间: 0.08s Refine Results
  1. 1
    Editorial: Proglucagon-Derived Peptides

    Editorial: Proglucagon-Derived Peptides 由 Peter R. Flatt, Filip K. Knop, Filip K. Knop, Filip K. Knop, Filip K. Knop, Andrei I. Tarasov

    出版 2021-11-01
    获取全文
    文件
  2. 2
    Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat

    Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver Fat 由 David S. Mathiesen, Asger Lund, Tina Vilsbøll, Tina Vilsbøll, Tina Vilsbøll, Filip K. Knop, Filip K. Knop, Filip K. Knop, Filip K. Knop, Jonatan I. Bagger, Jonatan I. Bagger

    出版 2021-01-01
    获取全文
    文件
  3. 3
    Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD

    Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD 由 Marta Seghieri, Marta Seghieri, Alexander S. Christensen, Andreas Andersen, Anna Solini, Filip K. Knop, Filip K. Knop, Filip K. Knop, Tina Vilsbøll, Tina Vilsbøll

    出版 2018-11-01
    获取全文
    文件
  4. 4
    A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment

    A glucose-insulin-glucagon coupled model of the isoglycemic intravenous glucose infusion experiment 由 Vijaya Subramanian, Jonatan I. Bagger, Jonatan I. Bagger, Jonatan I. Bagger, Jens J. Holst, Jens J. Holst, Filip K. Knop, Filip K. Knop, Filip K. Knop, Filip K. Knop, Tina Vilsbøll, Tina Vilsbøll, Tina Vilsbøll

    出版 2022-09-01
    获取全文
    文件
  5. 5
    Glucagon Receptor Signaling and Lipid Metabolism

    Glucagon Receptor Signaling and Lipid Metabolism 由 Katrine D. Galsgaard, Katrine D. Galsgaard, Jens Pedersen, Jens Pedersen, Filip K. Knop, Filip K. Knop, Filip K. Knop, Jens J. Holst, Jens J. Holst, Nicolai J. Wewer Albrechtsen, Nicolai J. Wewer Albrechtsen, Nicolai J. Wewer Albrechtsen

    出版 2019-04-01
    获取全文
    文件
  6. 6
    Hypoglycaemia and cardiac arrhythmias in diabetes

    Hypoglycaemia and cardiac arrhythmias in diabetes 由 Andreas Andersen, Peter G. Jørgensen, Filip K. Knop, Tina Vilsbøll

    出版 2020-05-01
    获取全文
    文件
  7. 7
    Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density

    Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral... 由 Robert Eriksson, Robert Eriksson, Brian V. Broberg, Pelle L. Ishøy, Nikolaj Bak, Ulrik B. Andersen, Niklas R. Jørgensen, Niklas R. Jørgensen, Filip K. Knop, Filip K. Knop, Filip K. Knop, Bjørn H. Ebdrup, Bjørn H. Ebdrup, Bjørn H. Ebdrup

    出版 2019-01-01
    获取全文
    文件
  8. 8
    Accuracy of continuous glucose monitoring during exercise-related hypoglycemia in individuals with type 1 diabetes

    Accuracy of continuous glucose monitoring during exercise-related hypoglycemia in individuals with type 1 diabetes 由 Kaisar Maytham, Kaisar Maytham, Per G. Hagelqvist, Per G. Hagelqvist, Susanne Engberg, Julie L. Forman, Ulrik Pedersen-Bjergaard, Ulrik Pedersen-Bjergaard, Filip K. Knop, Filip K. Knop, Filip K. Knop, Tina Vilsbøll, Tina Vilsbøll, Tina Vilsbøll, Andreas Andersen, Andreas Andersen

    出版 2024-04-01
    获取全文
    文件
  9. 9
    Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review

    Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes – a review 由 Katrine B Hansen, Tina Vilsbøll, Filip K Knop

    出版 2010-05-01
    获取全文
    文件
  10. 10
    Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake

    Protocol for assessing the effects of exogenous hormone administration on human postprandial glucose metabolism, appetite sensations, and food intake 由 Christoffer A. Hagemann, Lærke S. Gasbjerg, Mikkel B. Christensen, Filip K. Knop

    出版 2023-03-01
    获取全文
    文件
  11. 11
    Two weeks of acarbose treatment shows no effect on gut microbiome composition in patients with type 2 diabetes: a randomised, placebocontrolled, double-blind, crossover study

    Two weeks of acarbose treatment shows no effect on gut microbiome composition in patients with type 2 diabetes: a randomised, placebocontrolled, double-blind, crossover study 由 Niels B Dalsgaard, Lærke S Gasbjerg, Laura S Hansen, Dennis S Nielsen, Torben S Rasmussen, Filip K Knop

    出版 2024-07-01
    获取全文
    文件
  12. 12
    Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes.

    Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes. 由 Andrea Mari, Jonatan I Bagger, Ele Ferrannini, Jens J Holst, Filip K Knop, Tina Vilsbøll

    出版 2013-01-01
    获取全文
    文件
  13. 13
    Model‐Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans

    Model‐Based Prediction of Plasma Concentration and Enterohepatic Circulation of Total Bile Acids in Humans 由 Benjamin Guiastrennec, David P. Sonne, Martin Bergstrand, Tina Vilsbøll, Filip K. Knop, Mats O. Karlsson

    出版 2018-09-01
    获取全文
    文件
  14. 14
    No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course

    No changes in levels of bone formation and resorption markers following a broad-spectrum antibiotic course 由 Kristian H. Mikkelsen, Tina Vilsbøll, Jens J. Holst, Bolette Hartmann, Filip K. Knop, Morten Frost

    出版 2018-09-01
    获取全文
    文件
  15. 15
    Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives

    Metabolic profile in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives 由 Klara Coello, Maj Vinberg, Filip K. Knop, Bente K. Pedersen, Roger S. McIntyre, Lars V. Kessing, Klaus Munkholm

    出版 2019-04-01
    获取全文
    文件
  16. 16
    Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.

    Benefits and Harms of Sodium-Glucose Co-Transporter 2 Inhibitors in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis. 由 Heidi Storgaard, Lise L Gluud, Cathy Bennett, Magnus F Grøndahl, Mikkel B Christensen, Filip K Knop, Tina Vilsbøll

    出版 2016-01-01
    获取全文
    文件
  17. 17
    Supportive and non-supportive interactions in families with a type 2 diabetes patient: an integrative review

    Supportive and non-supportive interactions in families with a type 2 diabetes patient: an integrative review 由 Birgitte B. Bennich, Michael E. Røder, Dorthe Overgaard, Ingrid Egerod, Lene Munch, Filip K. Knop, Tina Vilsbøll, Hanne Konradsen

    出版 2017-07-01
    获取全文
    文件
  18. 18
    Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double-blind, randomised, placebo-controlled clinical trial

    Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double-blind, randomis... 由 Tina Vilsbøll, Filip K Knop, Mads M Helsted, Lærke S Gasbjerg, Casper K Nielsen, Julie L Forman, Mikkel B Christensen

    出版 2023-02-01
    获取全文
    文件
  19. 19
    Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, double-blind, placebo-controlled, investigator-initiated study

    Semaglutide treatment for PRevention Of Toxicity in high-dosE Chemotherapy with autologous haematopoietic stem-cell Transplantation (PROTECT): study protocol for a randomised, doub... 由 Filip K Knop, Hannelouise Kissow, Maria Ebbesen Sørum, Anne Ortved Gang, Dorte Maegaard Tholstrup, Sif Gudbrandsdottir, Brian Kornblit, Klaus Müller

    出版 2024-10-01
    获取全文
    文件
  20. 20
    evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease

    evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomat... 由 Jeffrey L. Cummings, Alireza Atri, Howard H. Feldman, Oskar Hansson, Mary Sano, Filip K. Knop, Peter Johannsen, Teresa León, Philip Scheltens

    出版 2025-01-01
    获取全文
    文件

检索工具: